Collaborative virtual reality improves walking
- Trial ID
- NCT07523425
- Official Title
- COMPARATIVE EFFECTIVENESS of COLLABORATIVE VIRTUAL ENVIRONMENT and NON-IMMERSIVE VIRTUAL REALITY in the REHABILITATION of PATIENTS With PARKINSON'S DISEASE
- Goal
- Collaborative virtual reality improves walking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Superior University
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson Desease
- Interventions
- Collaborative Virtual Environment, Non-Immersive Virtual Reality (NIVR)
Plain-Language Summary
Goal: to see whether a collaborative virtual environment where people work together in the same virtual space improves balance, gait, and everyday motor function more than standard non-immersive, screen-based virtual reality. Approach: participants do guided, task-based exercises using sensors or a screen, the collaborative setup adds social interaction and real-time visual and auditory feedback to boost motor learning, while the non-immersive option gives individual practice; both are rehab tools meant to complement, not replace, stable Parkinson's medications. Eligibility: adults 45 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages I to III, on stable conventional treatment, with no severe cognitive impairment (MMSE ≥ 24) and able to tolerate virtual sessions, excluding people with severe sensory problems, epilepsy, or other conditions that block participation.
Locations
- Punjab Institute of Neurosciences Lahore, Lahore, Punjab Province, Pakistan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Collaborative Virtual Environment. Goal: to see whether a collaborative virtual environment where people work together in the same virtual space improves balance, gait, and everyday motor function more than standard non-immersive, screen-based virtual reality. Approach: participants do guided, task-based exercises using sensors or a screen, the collaborative setup adds social interaction and real-time visual and auditory feedback to boost motor learning, while the non-immersive option gives individual practice; both are rehab tools meant to complement, not replace, stable Parkinson's medications. Eligibility: adults 45 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages I to III, on stable conventional treatment, with no severe cognitive impairment (MMSE ≥ 24) and able to tolerate virtual sessions, excluding people with severe sensory problems, epilepsy, or other conditions that block participation.
- Who can participate?
- Participants must be between 45 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 4 months.